{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:51:34Z","timestamp":1777535494157,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T00:00:00Z","timestamp":1366934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00262-013-1412-z","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T03:25:54Z","timestamp":1367378754000},"page":"1211-1222","source":"Crossref","is-referenced-by-count":8,"title":["EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors"],"prefix":"10.1007","volume":"62","author":[{"given":"Frank","family":"Neumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Kaddu-Mulindwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Dieter","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Held","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Kubuschok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,26]]},"reference":[{"key":"1412_CR1","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1073\/pnas.95.12.6919","volume":"95","author":"YT Chen","year":"1998","unstructured":"Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A, Old LJ (1998) Identification of multiple cancer\/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95:6919\u20136923","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR2","first-page":"1","volume":"4","author":"MJ Scanlan","year":"2004","unstructured":"Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer\/testis genes: review, standardization, and commentary. Cancer Immun 4:1","journal-title":"Cancer Immun"},{"key":"1412_CR3","first-page":"2617","volume":"178","author":"P Bruggen van der","year":"2007","unstructured":"van der Bruggen P, Traversari C, Chomez P, Lurquin C, De PE, Van den Eynde BJ, Knuth A, Boon T (2007) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. J Immunol 178:2617\u20132621","journal-title":"J Immunol"},{"key":"1412_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(95)80053-0","volume":"2","author":"P Boel","year":"1995","unstructured":"Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, van der Bruggen P (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167\u2013175","journal-title":"Immunity"},{"key":"1412_CR5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","volume":"182","author":"B Eynde Van den","year":"1995","unstructured":"Van den Eynde B, Peeters O, De BO, Gaugler B, Lucas S, Boon T (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689\u2013698","journal-title":"J Exp Med"},{"key":"1412_CR6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.10634","volume":"101","author":"AO Gure","year":"2002","unstructured":"Gure AO, Wei IJ, Old LJ, Chen YT (2002) The SSX gene family: characterization of 9 complete genes. Int J Cancer 101:448\u2013453","journal-title":"Int J Cancer"},{"key":"1412_CR7","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","volume":"94","author":"YT Chen","year":"1997","unstructured":"Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914\u20131918","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR8","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1073\/pnas.95.9.5211","volume":"95","author":"O Tureci","year":"1998","unstructured":"Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M (1998) Identification of a meiosis-specific protein as a member of the class of cancer\/testis antigens. Proc Natl Acad Sci USA 95:5211\u20135216","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR9","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/sj.onc.1205481","volume":"21","author":"O Tureci","year":"2002","unstructured":"Tureci O, Sahin U, Koslowski M, Buss B, Bell C, Ballweber P, Zwick C, Eberle T, Zuber M, Villena-Heinsen C, Seitz G, Pfreundschuh M (2002) A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing. Oncogene 21:3879\u20133888","journal-title":"Oncogene"},{"key":"1412_CR10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F","volume":"85","author":"AO Gure","year":"2000","unstructured":"Gure AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT (2000) CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 85:726\u2013732","journal-title":"Int J Cancer"},{"key":"1412_CR11","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","volume":"92","author":"U Sahin","year":"1995","unstructured":"Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810\u201311813","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3324\/haematol.2010.037978","volume":"96","author":"M Duin van","year":"2011","unstructured":"van Duin M, Broyl A, de Knegt Y, Goldschmidt H, Richardson PG, Hop WC, van der Holt B, Joseph-Pietras D, Mulligan G, Neuwirth R, Sahota SS, Sonneveld P (2011) Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy. Haematologica 96:1662\u20131669","journal-title":"Haematologica"},{"key":"1412_CR13","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood-2010-08-300376","volume":"117","author":"C Quintarelli","year":"2011","unstructured":"Quintarelli C, Dotti G, Hasan ST, De AB, Hoyos V, Errichiello S, Mims M, Luciano L, Shafer J, Leen AM, Heslop HE, Rooney CM et al (2011) High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells. Blood 117:3353\u20133362","journal-title":"Blood"},{"key":"1412_CR14","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1182\/blood-2011-07-365890","volume":"119","author":"S Ochsenreither","year":"2012","unstructured":"Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M, Warren EH, Hudecek M, Akatsuka Y et al (2012) Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood 119:5492\u20135501","journal-title":"Blood"},{"key":"1412_CR15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00262-002-0320-4","volume":"51","author":"S Huang","year":"2002","unstructured":"Huang S, Preuss KD, Xie X, Regitz E, Pfreundschuh M (2002) Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol Immunother 51:655\u2013662","journal-title":"Cancer Immunol Immunother"},{"key":"1412_CR16","first-page":"167","volume":"9","author":"X Xie","year":"2003","unstructured":"Xie X, Wacker HH, Huang S, Regitz E, Preuss KD, Romeike B, Parwaresch R, Tiemann M, Pfreundschuh M (2003) Differential expression of cancer testis genes in histological subtypes of non-Hodgkin\u2019s lymphomas. Clin Cancer Res 9:167\u2013173","journal-title":"Clin Cancer Res"},{"key":"1412_CR17","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-04-0079","volume":"64","author":"M Sugimoto","year":"2004","unstructured":"Sugimoto M, Tahara H, Ide T, Furuichi Y (2004) Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 64:3361\u20133364","journal-title":"Cancer Res"},{"key":"1412_CR18","first-page":"18","volume":"3","author":"C Wagner","year":"2003","unstructured":"Wagner C, Neumann F, Kubuschok B, Regitz E, Mischo A, Stevanovic S, Friedrich M, Schmidt W, Rammensee HG, Pfreundschuh M (2003) Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40\/SSX2. Cancer Immun 3:18","journal-title":"Cancer Immun"},{"key":"1412_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/CJI.0b013e31822b5b1d","volume":"34","author":"HA Smith","year":"2011","unstructured":"Smith HA, McNeel DG (2011) Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells. J Immunother 34:569\u2013580","journal-title":"J Immunother"},{"key":"1412_CR20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ijc.24850","volume":"126","author":"J Karbach","year":"2010","unstructured":"Karbach J, Gnjatic S, Bender A, Neumann A, Weidmann E, Yuan J, Ferrara CA, Hoffmann E, Old LJ, Altorki NK, Jager E (2010) Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival. Int J Cancer 126:909\u2013918","journal-title":"Int J Cancer"},{"key":"1412_CR21","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood-2005-04-1487","volume":"106","author":"F Neumann","year":"2005","unstructured":"Neumann F, Wagner C, Preuss KD, Kubuschok B, Schormann C, Stevanovic S, Pfreundschuh M (2005) Identification of an epitope derived from the cancer testis antigen HOM-TES-14\/SCP1 and presented by dendritic cells to circulating CD4+ T cells. Blood 106:3105\u20133113","journal-title":"Blood"},{"key":"1412_CR22","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1073\/pnas.0703342104","volume":"104","author":"K Odunsi","year":"2007","unstructured":"Odunsi K, Qian F, Matsuzaki J, Mhawech-Fauceglia P, Andrews C, Hoffman EW, Pan L, Ritter G, Villella J, Thomas B, Rodabaugh K, Lele S et al (2007) Vaccination with an NY-ESO-1 peptide of HLA class I\/II specificities induces integrated humoral and T cell responses in ovarian cancer. Proc Natl Acad Sci USA 104:12837\u201312842","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00262-011-1030-6","volume":"60","author":"F Neumann","year":"2011","unstructured":"Neumann F, Kubuschok B, Ertan K, Schormann C, Stevanovic S, Preuss KD, Schmidt W, Pfreundschuh M (2011) A peptide epitope derived from the cancer testis antigen HOM-MEL-40\/SSX2 capable of inducing CD4(+) and CD8(+) T-cell as well as B-cell responses. Cancer Immunol Immunother 60:1333\u20131346","journal-title":"Cancer Immunol Immunother"},{"key":"1412_CR24","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1073\/pnas.0707140104","volume":"105","author":"D Atanackovic","year":"2008","unstructured":"Atanackovic D, Altorki NK, Cao Y, Ritter E, Ferrara CA, Ritter G, Hoffman EW, Bokemeyer C, Old LJ, Gnjatic S (2008) Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming. Proc Natl Acad Sci USA 105:1650\u20131655","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.26074","volume":"130","author":"J Kawada","year":"2012","unstructured":"Kawada J, Wada H, Isobe M, Gnjatic S, Nishikawa H, Jungbluth AA, Okazaki N, Uenaka A, Nakamura Y, Fujiwara S, Mizuno N, Saika T et al (2012) Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination. Int J Cancer 130:584\u2013592","journal-title":"Int J Cancer"},{"key":"1412_CR26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.70.1.190","volume":"70","author":"G Miller","year":"1973","unstructured":"Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190\u2013194","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR27","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1038\/sj.onc.1204440","volume":"20","author":"M Mahyar-Roemer","year":"2001","unstructured":"Mahyar-Roemer M, Roemer K (2001) p21 Waf1\/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20:3387\u20133398","journal-title":"Oncogene"},{"key":"1412_CR28","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.exphem.2005.05.019","volume":"33","author":"TA Widmann","year":"2005","unstructured":"Widmann TA, Willmann B, Pfreundschuh M, Beelen DW (2005) Influence of telomere length on short-term recovery after allogeneic stem cell transplantation. Exp Hematol 33:1257\u20131261","journal-title":"Exp Hematol"},{"key":"1412_CR29","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1093\/nar\/gng003","volume":"31","author":"H Wege","year":"2003","unstructured":"Wege H, Chui MS, Le HT, Tran JM, Zern MA (2003) SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31:E3","journal-title":"Nucleic Acids Res"},{"key":"1412_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1097-0215(19980703)77:1<19::AID-IJC4>3.0.CO;2-2","volume":"77","author":"O Tureci","year":"1998","unstructured":"Tureci O, Chen YT, Sahin U, Gure AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M (1998) Expression of SSX genes in human tumors. Int J Cancer 77:19\u201323","journal-title":"Int J Cancer"},{"key":"1412_CR31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ijc.20006","volume":"109","author":"B Kubuschok","year":"2004","unstructured":"Kubuschok B, Xie X, Jesnowski R, Preuss KD, Romeike BF, Neumann F, Regitz E, Pistorius G, Schilling M, Scheunemann P, Izbicki JR, Lohr JM et al (2004) Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis. Int J Cancer 109:568\u2013575","journal-title":"Int J Cancer"},{"key":"1412_CR32","first-page":"11","volume":"2","author":"G Luo","year":"2002","unstructured":"Luo G, Huang S, Xie X, Stockert E, Chen YT, Kubuschok B, Pfreundschuh M (2002) Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immun 2:11","journal-title":"Cancer Immun"},{"key":"1412_CR33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.21352","volume":"118","author":"A Mischo","year":"2006","unstructured":"Mischo A, Kubuschok B, Ertan K, Preuss KD, Romeike B, Regitz E, Schormann C, de Bruijn D, Wadle A, Neumann F, Schmidt W, Renner C et al (2006) Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. Int J Cancer 118:696\u2013703","journal-title":"Int J Cancer"},{"key":"1412_CR34","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36","journal-title":"Nucleic Acids Res"},{"key":"1412_CR35","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.4049\/jimmunol.167.3.1712","volume":"167","author":"CM zum Buschenfelde","year":"2001","unstructured":"zum Buschenfelde CM, Metzger J, Hermann C, Nicklisch N, Peschel C, Bernhard H (2001) The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells. J Immunol 167:1712\u20131719","journal-title":"J Immunol"},{"key":"1412_CR36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.1282","volume":"92","author":"AA Jungbluth","year":"2001","unstructured":"Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ (2001) Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 92:856\u2013860","journal-title":"Int J Cancer"},{"key":"1412_CR37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S","volume":"80","author":"M Marchand","year":"1999","unstructured":"Marchand M, van Baren N, Weynants P, Brichard V, Dreno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R et al (1999) Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 80:219\u2013230","journal-title":"Int J Cancer"},{"key":"1412_CR38","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1073\/pnas.0403572101","volume":"101","author":"ID Davis","year":"2004","unstructured":"Davis ID, Chen W, Jackson H, Parente P, Shackleton M, Hopkins W, Chen Q, Dimopoulos N, Luke T, Murphy R, Scott AM, Maraskovsky E et al (2004) Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 101:10697\u201310702","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR39","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/10430340252898993","volume":"13","author":"B Kubuschok","year":"2002","unstructured":"Kubuschok B, Schmits R, Hartmann F, Cochlovius C, Breit R, Konig J, Pistorius G, Schilling M, Renner C, Pfreundschuh M (2002) Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model. Hum Gene Ther 13:815\u2013827","journal-title":"Hum Gene Ther"},{"key":"1412_CR40","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1089\/hum.2011.153","volume":"23","author":"B Kubuschok","year":"2012","unstructured":"Kubuschok B, Pfreundschuh M, Breit R, Hartmann F, Sester M, G\u00e4rtner B, K\u00f6nig J, Murawski N, Held G, Zwick C, Neumann F (2012) Mutated ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trial. Hum Gene Ther 23:1224\u20131236","journal-title":"Hum Gene Ther"},{"key":"1412_CR41","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","volume":"19","author":"SC De","year":"1999","unstructured":"De SC, Lurquin C, Lethe B, Martelange V, Boon T (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19:7327\u20137335","journal-title":"Mol Cell Biol"},{"key":"1412_CR42","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1074\/jbc.M510469200","volume":"281","author":"A Loriot","year":"2006","unstructured":"Loriot A, De PE, Boon T, De SC (2006) Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J Biol Chem 281:10118\u201310126","journal-title":"J Biol Chem"},{"key":"1412_CR43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"AJ Simpson","year":"2005","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ (2005) Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5:615\u2013625","journal-title":"Nat Rev Cancer"},{"key":"1412_CR44","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1183\/09031936.00081310","volume":"38","author":"S Leclercq","year":"2011","unstructured":"Leclercq S, Gueugnon F, Boutin B, Guillot F, Blanquart C, Rogel A, Padieu M, Pouliquen D, Fonteneau JF, Gregoire M (2011) A 5-aza-2\u2032-deoxycytidine\/valproate combination induces cytotoxic T-cell response against mesothelioma. Eur Respir J 38:1105\u20131116","journal-title":"Eur Respir J"},{"key":"1412_CR45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11060-008-9732-0","volume":"92","author":"S Oi","year":"2009","unstructured":"Oi S, Natsume A, Ito M, Kondo Y, Shimato S, Maeda Y, Saito K, Wakabayashi T (2009) Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2\u2032-deoxycytidine in glioma cells. J Neurooncol 92:15\u201322","journal-title":"J Neurooncol"},{"key":"1412_CR46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1541-7786.MCR-05-0229","volume":"4","author":"F Wischnewski","year":"2006","unstructured":"Wischnewski F, Pantel K, Schwarzenbach H (2006) Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res 4:339\u2013349","journal-title":"Mol Cancer Res"},{"key":"1412_CR47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13148-011-0031-9","volume":"2","author":"A Kuendgen","year":"2012","unstructured":"Kuendgen A, Bug G, Ottmann OG, Haase D, Schanz J, Hildebrandt B, Nachtkamp K, Neukirchen J, Dienst A, Haas R, Germing U, Gattermann N (2012) Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid. Clin Epigenet 2:389\u2013399","journal-title":"Clin Epigenet"},{"key":"1412_CR48","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1182\/blood-2009-11-249474","volume":"116","author":"O Goodyear","year":"2010","unstructured":"Goodyear O, Agathanggelou A, Novitzky-Basso I, Siddique S, McSkeane T, Ryan G, Vyas P, Cavenagh J, Stankovic T, Moss P, Craddock C (2010) Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myeloidplasia. Blood 116:1908\u20131918","journal-title":"Blood"},{"key":"1412_CR49","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1073\/pnas.1117208109","volume":"109","author":"K Odunsi","year":"2012","unstructured":"Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison CD, Ritter G, Godoy H, Lele S, duPont N et al (2012) Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci USA 109:5797\u20135802","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR50","doi-asserted-by":"crossref","first-page":"19695","DOI":"10.1073\/pnas.1110030108","volume":"108","author":"C Junqueira","year":"2011","unstructured":"Junqueira C, Santos LI, Galvao-Filho B, Teixeira SM, Rodrigues FG, DaRocha WD, Chiari E, Jungbluth AA, Ritter G, Gnjatic S, Old LJ, Gazzinelli RT (2011) Trypanosoma cruzi as an effective cancer antigen delivery vector. Proc Natl Acad Sci USA 108:19695\u201319700","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR51","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-12-1116","volume":"18","author":"J Karbach","year":"2012","unstructured":"Karbach J, Neumann A, Brand K, Wahle C, Siegel E, Maeurer MJ, Ritter E, Tsuji T, Gnjatic S, Old LJ, Ritter G, Jager E (2012) Phase I clinical trial of Mixed Bacterial Vaccine (Coley\u2019s Toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clin Cancer Res 18:5449\u20135459","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1412-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-013-1412-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1412-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T22:18:27Z","timestamp":1715293107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-013-1412-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,26]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1007\/s00262-013-1412-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,26]]}}}